Literature DB >> 17498260

Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus.

Carla S Coffin1, Patricia M Mulrooney-Cousins, Samuel S Lee, Tomasz I Michalak, Mark G Swain.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) share similar transmission routes; thus, coinfection is frequent. The consequences of acute HBV infection in patients with chronic hepatitis C are unknown.
METHODS: We describe a 47-year-old male with chronic hepatitis C who acquired HBV and then spontaneously and apparently completely cleared HCV but developed chronic hepatitis B. Five serum samples collected over 14 months and lymphoid cells obtained after acquiring HBV were tested for HCV and HBV by both standard assays and ultra-sensitive polymerase chain reaction/nucleic acid hybridization (PCR/NAH) (sensitivity approximately 2 IU/ml).
RESULTS: After superinfection with HBV, HBV surface antigen-positive chronic hepatitis developed with readily detectable HBV DNA. All sera collected after acquisition of HBV, which tested negative for HCV RNA by standard laboratory assay, were positive for HCV genomes when analysed by PCR/NAH. Peripheral lymphoid cells carried HBV DNA and covalently closed circular DNA, but were negative for HCV.
CONCLUSIONS: This is the first reported case of profound suppression of chronic hepatitis C after superinfection with HBV and establishment of chronic hepatitis B. It is hypothesized that HBV infection precipitated generalized and/or virus-specific cellular immune responses that profoundly suppressed HCV replication and yet failed to inhibit progression to chronic hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498260     DOI: 10.1111/j.1478-3231.2007.01477.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  8 in total

1.  Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Authors:  C S Coffin; P G Stock; L M Dove; C L Berg; N N Nissen; M P Curry; M Ragni; F G Regenstein; K E Sherman; M E Roland; N A Terrault
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

2.  Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

Authors:  C S Coffin; P M Mulrooney-Cousins; M G Peters; G van Marle; J P Roberts; T I Michalak; N A Terrault
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

Review 3.  Hepatitis B virus and hepatitis C virus dual infection.

Authors:  Gaia Caccamo; Francesca Saffioti; Giovanni Raimondo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  De Novo Superinfection of Hepatitis B Virus in an Anti-HBs Positive Patient with Recurrent Hepatitis C Following Liver Transplantation.

Authors:  Sung-Hae Ha; Young-Min Park; Sun-Pyo Hong; So-Ya Back; Soo-Kyeong Shin; Seung-Il Ji; Soo-Ok Kim; Wang-Don Yoo; Bo-Hyun Kim; Sang-Jong Park; Zheng Hong
Journal:  Gut Liver       Date:  2011-06-23       Impact factor: 4.519

5.  Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.

Authors:  Z Lee; S Nishikawa; S Gao; J B Eksteen; M Czub; M J Gill; C Osiowy; F van der Meer; G van Marle; C S Coffin
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

6.  Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.

Authors:  Ioanna Aggeletopoulou; Christos Konstantakis; Spilios Manolakopoulos; Christos Triantos
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

Review 7.  Identification and distribution of pathogens coinfecting with Brucella spp., Coxiella burnetii and Rift Valley fever virus in humans, livestock and wildlife.

Authors:  Earl A Middlebrook; Alicia T Romero; Bernard Bett; Daniel Nthiwa; Samuel O Oyola; Jeanne M Fair; Andrew W Bartlow
Journal:  Zoonoses Public Health       Date:  2022-01-15       Impact factor: 2.954

8.  Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies.

Authors:  Yi-Tse Su; Ming-Ling Chang; Rong-Nan Chien; Yun-Fan Liaw
Journal:  Viruses       Date:  2022-08-24       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.